Melodie S. Young

发表

A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 2

B. Strober, A. Gottlieb, A. Kavanaugh, 2012, Dermatology and Therapy.

National Psoriasis Foundation clinical consensus on disease severity.

Elizabeth J Horn, B. Strober, M. Lebwohl, 2007, Archives of dermatology.

From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasis.

B. Strober, M. Lebwohl, A. Kimball, 2008, Journal of the American Academy of Dermatology.

Treatment of Psoriasis in the Setting of Excessive Alcohol Intake: From the Medical Board of the National Psoriasis Foundation

A. Gottlieb, M. Lebwohl, A. Blauvelt, 2011 .

Treatment of erythrodermic psoriasis: from the medical board of the National Psoriasis Foundation.

M. Lebwohl, M. Rosenbach, B. Bebo, 2010, Journal of the American Academy of Dermatology.

Treatment of intertriginous psoriasis: from the Medical Board of the National Psoriasis Foundation.

M. Lebwohl, E. Horn, N. Korman, 2009, Journal of the American Academy of Dermatology.

Treatment of severe scalp psoriasis: from the Medical Board of the National Psoriasis Foundation.

M. Lebwohl, B. Bebo, N. Korman, 2009, Journal of the American Academy of Dermatology.

Recommendations for Initiating Systemic Therapy in Patients with Psoriasis.

G. Martin, Lakshi M. Aldredge, Melodie S. Young, 2019, The Journal of clinical and aesthetic dermatology.

Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor: A novel treatment option for nurse practitioners treating patients with psoriatic disease

Melodie S. Young, Heather L. Roebuck, 2016, Journal of the American Association of Nurse Practitioners.

The ACCEPT study: ustekinumab versus etanercept in moderate-to-severe psoriasis patients

Elizabeth J Horn, E. Horn, J. Cather, 2011, Expert review of clinical immunology.

Mechanistic Insights Into Today’s (and Tomorrow’s) Treatments for Moderate-to-Severe Psoriasis

Melodie S. Young, K. Kucera, 2016 .

Defining Inadequate Response to Biologic Psoriasis Treatments: Considering Alternative Biologic Therapy

Melodie S. Young, Linda Daus, E. Elliott, 2009 .

A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 2

B. Strober, A. Gottlieb, A. Kavanaugh, 2012, Dermatology and Therapy.

A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 1

B. Strober, A. Gottlieb, A. Kavanaugh, 2012, Dermatology and Therapy.

Psoriasis for the primary care practitioner

Lakshi M. Aldredge, Melodie S. Young, Patti Parker, 2017, Journal of the American Association of Nurse Practitioners.

Providing Guidance for Patients With Moderate-to-Severe Psoriasis Who Are Candidates for Biologic Therapy

Lakshi M. Aldredge, Melodie S. Young, 2016, Journal of the Dermatology Nurses' Association.

A Review of Phase 3 Trials of Dupilumab for the Treatment of Atopic Dermatitis in Adults, Adolescents, and Children Aged 6 and Up

J. Cather, S. Tofte, Melodie S. Young, 2022, Dermatology and Therapy.

A Review of Phase 3 Trials of Dupilumab for the Treatment of Atopic Dermatitis in Adults, Adolescents, and Children Aged 6 and Up

J. Cather, S. Tofte, Melodie S. Young, 2022, Dermatology and Therapy.

Diagnosis and Management of Psoriatic Arthritis: A Practical Review

N. Furfaro, Melodie S. Young, A. Rai, 2009 .

Adalimumab in dermatology

J. Cather, Melodie S. Young, 2006 .

Candida Infections in Clinical Trials of Ixekizumab (Taltz), an Interleukin-17A Monoclonal Antibody, in Patients With Psoriasis or Psoriatic Arthritis

Melodie S. Young, T. Ridenour, Wen Xu, 2019, Journal of the Dermatology Nurses' Association.

Practical considerations in future psoriasis therapies.

A. Menter, Melodie S. Young, Christy C. Riddle, 2004, Dermatologic clinics.

A series of critically challenging case scenarios in moderate to severe psoriasis: a Delphi consensus approach.

Elizabeth J Horn, B. Strober, A. Gottlieb, 2009, Journal of the American Academy of Dermatology.

Onychomycosis: Burden of Illness and Successful Treatment With a New Topical Antifungal

Melodie S. Young, 2014 .

National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents.

M. Lebwohl, N. Korman, S. Doherty, 2008, Journal of the American Academy of Dermatology.

Broadening the Scope of Nursing Practice

Melodie S. Young, 2011 .

Quality of Life in the Dermatology Practice

J. Cather, J. Cather, Melodie S. Young, 2018 .

Obesity and psoriasis: from the Medical Board of the National Psoriasis Foundation.

M. Lebwohl, Samuel F Bremmer, A. Blauvelt, 2010, Journal of the American Academy of Dermatology.

Managing inflammatory arthritides: Role of the nurse practitioner and physician assistant

R. Higham, Melodie S. Young, M. Lesko, 2010, Journal of the American Academy of Nurse Practitioners.

Successful treatment of hand and foot psoriasis with efalizumab therapy.

Loretta Jones, J. Crowley, J. Sobell, 2006, Journal of drugs in dermatology : JDD.

Improving clinical trial design in psoriasis: Perspectives from the global dermatology community

E. Horn, A. Menter, W. Sterry, 2011, Journal of dermatological treatment (Print).

National Psoriasis Tissue Bank

A. Bowcock, A. Menter, L. Morris, 1995 .

The psychological and social burdens of psoriasis.

Melodie S. Young, 2005, Dermatology nursing.

The incidence and management of infusion reactions to infliximab: A large center experience

Melodie S. Young, 2003 .

Integrating biologic therapies into a dermatology practice: practical and economic considerations.

Melodie S. Young, M. Craze, 2003, Journal of the American Academy of Dermatology.